内皮功能障碍和促炎状态决定了严重的血液毒性和CAR-T治疗的劣质结果
Lukas Scheller1,2,3,4, Xiang Zhou1, Henry Loeffler-Wirth5
1Medizinische Klinik und Poliklinik II Universitätsklinikum Würzburg Würzburg Germany.
HemaSphere
|December 10, 2025
概括
预测生物标志物可溶性VCAM-1和sIL-2R在化学抗原受体 (CAR) -T治疗后识别出患有严重血毒性和感染高风险的患者,改善了患者管理.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物标志物发现发现
背景情况:
- 血液毒性和感染是后化学抗原受体 (CAR) -T疗法死亡的主要原因.
- 可靠的预测生物标志物对于改善风险评估和患者管理至关重要.
研究的目的:
- 通过免疫相关的不良结果途径概念,识别CAR-T相关血液毒性的预测生物标志物.
- 评估特定生物标志物与临床结果的相关性.
主要方法:
- 在CAR-T输注前后对78名患者进行了流细胞计和多重检测.
- 分析了包括可溶性VCAM-1 (sVCAM-1) 和可溶性IL-2R (sIL-2R) 在内的关键生物标志物.
- 统计分析将生物标志物水平与血液毒性,感染和整体存活率相关联.
主要成果:
- 严重的血液毒性与内皮功能障碍标志物相关,如增加的sVCAM-1.
- 升高的基线sVCAM-1和sIL-2R预测了总体存活率的降低,长时间的中性质减退和更严重的感染.
- 这些生物标志物显示出独立于临床变量的预测价值.
结论:
- 基线sVCAM-1和sIL-2R是CAR-T治疗中不良结果的强有力的预测生物标志物.
- 整合这些标志物可以完善风险分层,并指导个性化的患者管理.
- 这项研究突出了与免疫相关的不良结果途径在生物标志物发现方面的潜力.
相关概念视频
Regulation of Hematopoietic Stem Cells
3.9K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.9K
Myocarditis I: Introduction
341
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
341
Role of Hematopoietic Growth Factors
3.1K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
3.1K
Disorders of Hemostasis
1.9K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.9K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
200
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
200
Stem Cell Therapy for Tissue Regeneration
4.6K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.6K
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)

